A

Alibaba Health Information Technology Ltd
HKEX:241

Watchlist Manager
Alibaba Health Information Technology Ltd
HKEX:241
Watchlist
Price: 3.61 HKD -4.75% Market Closed
Market Cap: 58B HKD
Have any thoughts about
Alibaba Health Information Technology Ltd?
Write Note

Alibaba Health Information Technology Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Alibaba Health Information Technology Ltd
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
A
Alibaba Health Information Technology Ltd
HKEX:241
Cost of Revenue
-ÂĄ21.8B
CAGR 3-Years
-16%
CAGR 5-Years
-32%
CAGR 10-Years
-107%
China Ruyi Holdings Ltd
HKEX:136
Cost of Revenue
-ÂĄ1.9B
CAGR 3-Years
-25%
CAGR 5-Years
-65%
CAGR 10-Years
N/A
Cybernaut International Holdings Co Ltd
HKEX:1020
Cost of Revenue
-ÂĄ102.9m
CAGR 3-Years
14%
CAGR 5-Years
16%
CAGR 10-Years
7%
Y
YesAsia Holdings Ltd
HKEX:2209
Cost of Revenue
-$138.6m
CAGR 3-Years
-8%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Hong Kong Technology Venture Co Ltd
HKEX:1137
Cost of Revenue
-HK$1.9B
CAGR 3-Years
-6%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Y
Yoho Group Holdings Ltd
HKEX:2347
Cost of Revenue
-HK$719.3m
CAGR 3-Years
-19%
CAGR 5-Years
-48%
CAGR 10-Years
N/A
No Stocks Found

Alibaba Health Information Technology Ltd
Glance View

Market Cap
58B HKD
Industry
Retail

Alibaba Health Information Technology Ltd. is a key player in the rapidly evolving landscape of digital healthcare in China, one of the world's largest markets for health services. This innovative subsidiary of Alibaba Group was founded in 2014, aiming to harness the power of advanced technology to enhance healthcare accessibility and efficiency. By leveraging big data, artificial intelligence, and cloud computing, Alibaba Health develops a comprehensive ecosystem that connects patients and healthcare providers seamlessly. Their platforms enable users to book appointments, purchase medications online, and access personalized health information, thereby improving overall health management for millions of individuals across China. As an investor, one cannot overlook Alibaba Health's strategic position in the booming digital healthcare sector fueled by an aging population and rising health awareness among Chinese consumers. The company has established significant partnerships with hospitals, pharmacies, and other healthcare stakeholders, facilitating integration across the health system. With its robust technological infrastructure and the backing of the Alibaba Group, Alibaba Health is well-equipped to capitalize on emerging trends and regulatory shifts in China's healthcare environment. Their ambitious growth strategy and commitment to innovation position them as a potential long-term investment, promising not only strong financial returns but also a meaningful impact on the lives of individuals seeking quality healthcare services.

Intrinsic Value
2.69 HKD
Overvaluation 26%
Intrinsic Value
Price
A

See Also

What is Alibaba Health Information Technology Ltd's Cost of Revenue?
Cost of Revenue
-21.8B CNY

Based on the financial report for Sep 30, 2024, Alibaba Health Information Technology Ltd's Cost of Revenue amounts to -21.8B CNY.

What is Alibaba Health Information Technology Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-107%

Over the last year, the Cost of Revenue growth was 1%. The average annual Cost of Revenue growth rates for Alibaba Health Information Technology Ltd have been -16% over the past three years , -32% over the past five years , and -107% over the past ten years .

Back to Top